68Ga-PRGD2 PET/CT in the Evaluation of Glioma: A Prospective Study | Zendy

Deling Li | Zendy; Xiaobin Zhao | Zendy; Liwei Zhang | Zendy; Fang Li | Zendy; Nan Ji | Zendy; Zhixian Gao | Zendy; Jisheng Wang | Zendy; Peng Kang | Zendy; Zhaofei Liu | Zendy; Jiyun Shi | Zendy; Xiaohong Chen | Zendy; Zhaohui Zhu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

⁶⁸Ga-PRGD2 PET/CT in the Evaluation of Glioma: A Prospective Study

Author(s) -

Deling Li,

Xiaobin Zhao,

Liwei Zhang,

Fang Li,

Nan Ji,

Zhixian Gao,

Jisheng Wang,

Peng Kang,

Zhaofei Liu,

Jiyun Shi,

Xiaohong Chen,

Zhaohui Zhu

Publication year - 2014

Publication title -

molecular pharmaceutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.13

H-Index - 127

eISSN - 1543-8392

pISSN - 1543-8384

DOI - 10.1021/mp5003224

Subject(s) - glioma , medicine , grading (engineering) , magnetic resonance imaging , nuclear medicine , pathology , immunohistochemistry , choroid plexus , radiology , cancer research , biology , central nervous system , ecology

Integrin αvβ3 is overexpressed in both neovasculature and glioma cells. We aimed to evaluate (68)gallium-BNOTA-PRGD2 ((68)Ga-PRGD2) as a new reagent for noninvasive integrin αvβ3 imaging in glioma patients. With informed consent, 12 patients with suspicious brain glioma, as diagnosed by enhanced magnetic resonance imaging (MRI) scanning, were enrolled to undergo (68)Ga-PRGD2 PET/CT and (18)F-FDG PET/CT scans before surgery. The preoperative images were compared and correlated with the pathologically determined WHO grade. Next, the expression of integrin αvβ3, CD34, and Ki-67 were determined by immunohistochemical staining of the resected brain tumor tissue. Our findings demonstrated that (68)Ga-PRGD2 specifically accumulated in the brain tumors that were rich of integrin αvβ3 and other neovasculature markers, but not in the brain parenchyma other than the choroid plexus. Therefore, (68)Ga-PRGD2 PET/CT was able to evaluate the glioma demarcation more specifically than (18)F-FDG PET/CT. The maximum standardized uptake values (SUVmax) of (68)Ga-PRGD2, rather than those of (18)F-FDG, were significantly correlated with the glioma grading. The maximum tumor-to-brain ratios (TBRmax) of both tracers were significantly correlated with glioma grading, whereas (68)Ga-PRGD2 seemed to be more superior to (18)F-FDG in differentiating high-grade glioma (HGG) from low-grade glioma (LGG). Moreover, (68)Ga-PRGD2 PET/CT showed different accumulation patterns for HGG of WHO grades III and IV. This is the first noninvasive integrin imaging study, to the best of our knowledge, conducted in preoperative patients with different grades of glioma, and it preliminarily indicated the effectiveness of this novel method for evaluating glioma grading and demarcation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research